Bruker Corporation (Nasdaq: BRKR) has acquired the DISQVER® clinical metagenomics platform from Noscendo GmbH, adding metagenomic next-generation sequencing (mNGS) capabilities ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions